News and Announcements
Leaf Resources Placement Raises $795,000
- Published June 07, 2016 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
6th June 2016, ASX Announcement
Leaf Resources would like to advise that they have received commitments, principally through Lodge Partners from sophisticated investors for a placement of 7,250,00 ordinary shares at an issue price of $0.10 as well as a conversion of 700,00 options exercisable at $0.10 thereby raising a total of $795,000.
The placement price of $0.10 was the closest market price at the close of business on Wednesday 1st June 2016, when the company suspended its shares.
In addition to the funds from the placement, the company is expecting to receive a total of over $650,00 from Joint Venture research fees, the Export Market Development Grant program and the R & D Tax Rebate in the near future.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
